Arcadia Science
Arcadia Science is a private Emeryville-based evolutionary biology company building Zoogle, an organismal search tool that uses billions of years of evolutionary data to predict the best research models for human biology, serving academic, pharma, and biotech researchers via an open-science distribution model.
- Company typePrivate
- Founded2021
- HeadquartersBerkeley, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Arcadia Science does
Arcadia Science is an evolutionary biology company developing methods to predict and test therapeutics by leveraging billions of years of evolutionary data. The company is structured around the thesis that evolution itself is the world's largest R&D program and that its structure can be used to inform every stage of the drug development cycle — from organism selection to therapeutic hypothesis generation. The platform is horizontally aimed at the scientific research community, including academics, pharmaceutical companies, and biotech researchers who need better organism models for studying human biology.
The company's core product is Zoogle, a web portal launched in February 2025 that serves as an organismal search tool. Zoogle takes evolutionary data across species and uses it to predict which organisms are the most relevant biological models for different aspects of human biology. Beyond Zoogle, Arcadia releases software pipelines, apps, protocols, and other research resources under an open-science publishing model, distributing via GitHub, Substack, blog, and social channels. The stated revenue model is subscription/recurring for its research platform and tools, though pricing is not publicly disclosed and no specific paying customers are named.
Arcadia is incorporated as a private for-profit entity based in Emeryville, California (6401 Hollis Street, Suite 100), with 11–50 employees. Its leadership is composed of co-founders Seemay Chou (CEO), Prachee Avasthi (CSO and CSA), and Jed McCaleb (Co-Founder, Board Member and Advisor to the CEO) — a configuration that combines academic biology leadership with a high-profile technology entrepreneur. Most recently, the company announced two research partnerships in August 2025 to investigate predicted disease-organism matches, representing an early step from internal research toward externally-validated, partnership-driven use of its platform.
Arcadia Science firmographics
Firmographics- Name
- Arcadia Science
- Legal name
- Arcadia Science
- Website
- https://arcadia.science
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Arcadia Science is a private Emeryville-based evolutionary biology company building Zoogle, an organismal search tool that uses billions of years of evolutionary data to predict the best research models for human biology, serving academic, pharma, and biotech researchers via an open-science distribution model.
- Ownership category
- akta.pro rank
Arcadia Science industry classification
Industry- Product category
- Drug Discovery & Biotechnology Research Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industry
- Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
Keywords
Where Arcadia Science is headquartered
LocationHeadquarters
- HQ city
- Berkeley
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Arcadia Science business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Research Platform & Tools: Developing a platform for predicting and testing therapeutics based on evolutionary biology insights. The company releases tools, apps, and software pipelines to the scientific community, potentially through partnerships with pharmaceutical companies or research institutions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Arcadia Science product offering
Product offeringCore offering
Arcadia Science develops Zoogle, a web portal that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology. The company is also building an evolutionary biology platform that uses the structure of evolution to inform efforts across the research and development cycle for predicting and testing therapeutics. It releases apps, software pipelines, protocols, and other resources to the scientific community as part of an open science approach.
Product overview
Arcadia Science is an evolutionary biology company developing better ways to predict and test therapeutics. Their main product is Zoogle, an organismal search tool. They also offer a platform for research and development, and release various tools including apps, software pipelines, and protocols to the scientific community as part of their open science approach.
Differentiator
Problem solved
Functional benefit
Brands
- Zoogle: An organismal search tool that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology.
Products and services
- Zoogle A web portal / organismal search tool that leverages billions of years of evolutionary data to help researchers predict which organisms are the most relevant models for different aspects of human biology. Intended for researchers in academic institutions, pharmaceutical companies, and biotech firms working on therapeutic prediction and model organism selection.
Companies that use Arcadia Science
Customer profileSegments1 record
Ideal customer profiles1 record
Arcadia Science technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Arcadia Science partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Arcadia Science competitors and assessment
Company assessmentDirect peers
- Recursion Pharmaceuticals: AI-driven drug discovery platform using high-throughput biology and computational tools to identify therapeutics. Direct peer because both target therapeutic prediction through biological data and computational methods, though Recursion is much larger and more capital-intensive.
- Insitro: Machine learning-driven drug discovery company combining biology and AI to predict therapeutic outcomes. Comparable to Arcadia in its mission to use data-driven biology to inform drug development, though Insitro focuses on cell-based phenotypic data.
- Isomorphic Labs: Alphabet/DeepMind spinoff applying AI to drug discovery with a focus on novel protein structure prediction. A direct competitor in AI-informed therapeutic development, though with vastly greater resources and a different core methodology.
- Genesis Therapeutics: AI-native drug discovery company using graph neural networks and molecular simulation to predict drug behavior. Comparable in using computational methods to predict therapeutic properties and working with emerging biology.
- Atomwise: AI-driven small molecule drug discovery company using structure-based design and prediction. Comparable in applying AI/ML to predict therapeutic candidates and inform R&D decisions.
Broad incumbents
- Benchling: Cloud-based life sciences R&D platform serving biotech and pharma with informatics tools. Broader incumbent in life science software, relevant as a comparator for Arcadia's software platform ambitions in the research informatics space.
- DNAnexus: Biomedical informatics and data management platform for genomics and clinical research. Comparable as a bioinformatics and multi-omics data platform serving the same scientific community Arcadia targets.
Emerging players
- EvolutionaryScale: AI research lab building large language models of protein sequences inspired by evolutionary biology. Emerging peer with direct conceptual overlap to Arcadia's use of evolutionary data, though focused on protein design rather than organism selection.
Others
- Jackson Laboratory (JAX): Non-profit biomedical research institution specializing in mouse model organisms and human genomics. Comparable as an ecosystem player curating model organism data and supporting translational research, though a non-profit rather than a commercial competitor.
- Allen Institute: Non-profit research organization conducting open science in biology and neuroscience, releasing data and tools publicly. Adjacent peer that shares Arcadia's open-science philosophy and contributes model organism resources to the community.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Arcadia Science social profiles
Digital presenceArcadia Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arcadia Science leadership team
Management profileNumber of profiles
Profiles3 records
Arcadia Science funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arcadia Science M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arcadia Science
What does Arcadia Science do?
Arcadia Science develops Zoogle, a web portal that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology. The company is also building an evolutionary biology platform that uses the structure of evolution to inform efforts across the research and development cycle for predicting and testing therapeutics. It releases apps, software pipelines, protocols, and other resources to the scientific community as part of an open science approach.
Is Arcadia Science a public or private company?
Arcadia Science is a private company. It is classified as unknown and is currently operating.
When was Arcadia Science founded?
Arcadia Science was founded in 2021. It employs 11 to 50 people.
Where is Arcadia Science based?
Arcadia Science is headquartered in Berkeley, United States, in the North America region.
How does Arcadia Science make money?
One revenue line is on record: research Platform & Tools.
Who are Arcadia Science's main competitors?
Direct peers on record are Recursion Pharmaceuticals, Insitro, Isomorphic Labs, Genesis Therapeutics and Atomwise. Broad incumbents are Benchling and DNAnexus. EvolutionaryScale is listed as an emerging player. Others are Jackson Laboratory (JAX) and Allen Institute.
Does Arcadia Science have an API?
No public API is recorded for Arcadia Science.
What industry is Arcadia Science in?
Arcadia Science's product category is Drug Discovery & Biotechnology Research Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization). Its NAICS code is 5132 and its SIC code is 8731.